Six health start-ups to get Rs 65 lakhs each under Pfizer's INDovation programme
Pfizer will provide the grant as well as mentorship and technical assistance to the six winning health start-ups while its programme partner Social Alpha will provide the programme acceleration support.
Canada approves Pfizer Covid-19 vaccine for kids under five years
Health Canada has approved Pfizer's Covid-19 vaccine to immunise children under the age of five
Heart inflammation risk after Covid-19 booster rare in young men: Study
The risk of developing myocarditis among males ages 16 to 19 years are about one in 15,000 after the third dose of the Pfizer-BioNTech Covid-19 vaccine, however the cases are rare and mild.
PFIZER LTD. - 500680 - Outcome Of The Board Meeting - Declaration Of Interim (Special) Dividend For The Financial Year Ending March 31, 2023, And Intimation Of Record Date.
The Board of Directors at its meeting held today, i.e., September 6, 2022 has declared an Interim (Special) Dividend of Rs. 30/- per equity share of Rs. 10/- each (300%) for the financial year ending March 31, 2023, in view of the gain on account of sale of Upjohn Business to Mylan Pharmaceuticals Private Limited. The said Board Meeting commenced at 11.45 a.m. and concluded at 12.40 p.m. The said Interim Dividend will be paid to the eligible Members of the Company on or before Friday, September 30, 2022. We further inform you that the Record Date for the payment of aforementioned Dividend of Rs. 30/- (300%) per equity share is Tuesday, September 20, 2022. PFIZER LTD. - 500680 - Board Meeting Outcome for Outcome Of The Board Meeting - Declaration Of Interim (Special) Dividend For The Financial Year Ending March 31, 2023, And Intimation Of Record Date.
The Board of Directors at its meeting held today, i.e., September 6, 2022 has declared an Interim (Special) Dividend of Rs. 30/- per equity share of Rs. 10/- each (300%) for the financial year ending March 31, 2023, in view of the gain on account of sale of Upjohn Business to Mylan Pharmaceuticals Private Limited. The said Board Meeting commenced at 11.45 a.m. and concluded at 12.40 p.m. The said Interim Dividend will be paid to the eligible Members of the Company on or before Friday, September 30, 2022. We further inform you that the Record Date for the payment of aforementioned Dividend of Rs. 30/- (300%) per equity share is Tuesday, September 20, 2022. We request you to kindly take the same on record. New Covid boosters for Omicron strains to roll out soon as CDC gives nod
New COVID-19 boosters that target today's most common omicron strains are set to begin soon after the Centers for Disease Control and Prevention endorsed the updated shots. The decision by CDC Director Rochelle Walensky on Thursday came shortly after the agency's advisers said if enough people roll up their sleeves, the shots could blunt a winter surge. They can help restore protection that has waned since previous vaccination and were designed to provide broader protection, she said in a statement. The tweaked shots made by Pfizer and rival Moderna offer Americans a chance to get the most up-to-date protection at yet another critical period in the pandemic. They're combination or bivalent shots half the original vaccine and half protection against the BA.4 and BA.5 omicron versions now causing nearly all COVID-19 infections. The CDC's advisers struggled with who should get the new booster and when because only a similarly tweaked vaccine, not the exact recipe, has been studied in PFIZER LTD. - 500680 - Board Meeting Intimation for Board Meeting To Consider Declaration Of Interim Dividend For The Financial Year Ending March 31, 2023.
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2022 ,inter alia, to consider and approve This is to inform you that a Meeting of Board of Directors of the Company is scheduled to be held on Tuesday, September 6, 2022, to consider declaration of Interim Dividend for the Financial Year ending March 31, 2023. Further please be informed that, Pursuant to the 'Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders' the Trading Window of the Company shall remain closed from Thursday, September 1, 2022 (close of business) till 48 hours after the declaration of Interim Dividend i.e., September 8, 2022 (close of business).
Germany's BioNTech gains emergency US approval for Omicron booster
The US FDA granted emergency use authorisation for a 30-microgram booster dose of the Pfizer-BioNTech Covid-19 vaccine, bivalent and Omicron BA.4/BA.5, for individuals aged 12 years and above Moderna-Pfizer spat: Friendly fire' that sets a worrying precedent, say experts
Late last week, Moderna said it was filing patent infringement lawsuits against Pfizer and BioNTech in the US and Germany PFIZER LTD. - 500680 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Pfizer Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here